Jamal Alzubi
-
- CAR-T cell therapy research 13
-
- Immune Cell Function and Interaction 2
-
- Virus-based gene therapy research 8
-
- CRISPR and Genetic Engineering 8
- Viral Infectious Diseases and Gene Expression in Insects 6
- Pluripotent Stem Cells Research 3
- RNA Interference and Gene Delivery 3
- Advanced biosensing and bioanalysis techniques 2
- Co-authors
- Toni CathomenClaudio MussolinoThomas LahayeThomas J. CradickRobert MorbitzerGang BaoEli J. FinePhilipp Wolf
- Partner nations
- GermanyUnited KingdomUnited States
In The Last Decade
Jamal Alzubi
18 papers receiving 447 citations
Peers
Comparison fields: 5 of 47
- Business and International Management 24
- Oncology 199
- Immunology 129
- Aging 10
- Virology 24
Countries citing papers authored by Jamal Alzubi
This map shows the geographic impact of Jamal Alzubi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jamal Alzubi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jamal Alzubi more than expected).
Fields of papers citing papers by Jamal Alzubi
This network shows the impact of papers produced by Jamal Alzubi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jamal Alzubi. The network helps show where Jamal Alzubi may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Jamal Alzubi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 2 | |
| 3 | 2025 | 0 | |
| 4 | 2024 | 3 | |
| 5 | 2023 | 8 | |
| 6 | 2023 | 1 | |
| 7 | 2022 | 52 | |
| 8 | 2022 | 16 | |
| 9 | 2021 | 38 | |
| 10 | 2021 | 10 | |
| 11 | 2020 | 41 | |
| 12 | 2020 | 8 | |
| 13 | 2020 | 41 | |
| 14 | 2019 | 31 | |
| 15 | 2017 | 15 | |
| 16 | 2017 | 6 | |
| 17 | 2015 | 9 | |
| 18 | 2014 | 23 | |
| 19 | 2014 | 131 | |
| 20 | 2013 | 17 |
About Jamal Alzubi
Jamal Alzubi is a scholar working on Aging, Business and International Management and Oncology, having authored 20 papers that have together received 452 indexed citations. Recurring topics across this work include CAR-T cell therapy research (13 papers), Virus-based gene therapy research (8 papers), CRISPR and Genetic Engineering (8 papers), Viral Infectious Diseases and Gene Expression in Insects (6 papers), Pluripotent Stem Cells Research (3 papers), RNA Interference and Gene Delivery (3 papers), Immune Cell Function and Interaction (2 papers) and Advanced biosensing and bioanalysis techniques (2 papers). The work is most often cited by research in Business and International Management (24 citations), Oncology (199 citations) and Immunology (129 citations). Jamal Alzubi has collaborated with scholars based in Germany, United Kingdom and United States. Frequent co-authors include Toni Cathomen, Claudio Mussolino, Thomas Lahaye, Thomas J. Cradick, Robert Morbitzer, Gang Bao, Eli J. Fine, Philipp Wolf, Christian Gratzke and Johannes Kuehle. Their work appears in journals such as Nucleic Acids Research, Blood and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.